Log in

Temporal changes in loss of life expectancy due to cancer in Australia: a flexible parametric approach

  • Original paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Purpose

To evaluate changes in cancer mortality burden over time by assessing temporal trends in life expectation for Australian residents diagnosed with cancer.

Methods

The study cohort consisted of all people diagnosed with cancer in the period 1990–2000 and aged 15–89 years (n = 1,275,978), with mortality follow-up to 31 December 2010. Flexible parametric survival models incorporating background age–sex–year-specific population mortality rates were applied to generate the observed survival curves for all cancers combined and selected major cancer types. Predicted values of loss of life expectancy (LOLE) in years were generated and then averaged across calendar year and age group (15–49, 50–69 and 70–89 years) or spread of disease (localized, regional, distant, unknown).

Results

The greatest LOLE burden was for lung cancer (14.3 years per diagnosis) and lowest for melanoma (2.5 years). There was a significant decrease in LOLE over time (−0.13 LOLE per year) for all cancers combined. Decreases were also observed for female breast cancer (−0.21), prostate cancer (−0.17), colorectal cancer (−0.08), melanoma (−0.07) and stomach cancer (−0.02), with slight increases for lung cancer (+0.04). When restricted to the sub-cohort from New South Wales with spread of disease information, these decreases in LOLE were primarily among cancers categorized as localized or regional spread at diagnosis.

Conclusions

In Australia, persons diagnosed with cancer have a steadily improving outlook that exceeds that expected by general improvement in population life expectancy. The overall improvement is observed in persons with localized or regional cancers but not in those with advanced cancers, findings which encourage earlier diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Brustugun OT, Moller B, Helland A (2014) Years of life lost as a measure of cancer burden on a national level. Br J Cancer 111:1014–1020

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Soneji S, Beltran-Sanchez H, Sox HC (2014) Assessing progress in reducing the burden of cancer mortality, 1985–2005. J Clin Oncol 32:444–448

    Article  PubMed  PubMed Central  Google Scholar 

  3. van Kruijsdijk RC, van der Graaf Y, Koffijberg H et al (2016) Cause-specific mortality and years of life lost in patients with different manifestations of vascular disease. Eur J Prev Cardiol 23:160–169

  4. Ibayashi H, Pham TM, Fu**o Y et al (2011) Estimation of premature mortality from oral cancer in Japan, 1995 and 2005. Cancer Epidemiol 35:342–344

    Article  PubMed  Google Scholar 

  5. Andersson TM, Dickman PW, Eloranta S, Lambe M, Lambert PC (2013) Estimating the loss in expectation of life due to cancer using flexible parametric survival models. Stat Med 32:5286–5300

    Article  PubMed  Google Scholar 

  6. Baade P, Youlden D, Andersson TM et al (2015) Estimating the change in life expectancy after a diagnosis of cancer among the Australian population. BMJ Open 5:e006740

    Article  PubMed  PubMed Central  Google Scholar 

  7. Royston P, Parmar MK (2002) Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 21:2175–2197

    Article  PubMed  Google Scholar 

  8. Hwang JS, Wang JD (1999) Monte Carlo estimation of extrapolation of quality-adjusted survival for follow-up studies. Stat Med 18:1627–1640

    Article  CAS  PubMed  Google Scholar 

  9. Hwang JS, Wang JD (2004) Integrating health profile with survival for quality of life assessment. Qual Life Res 13:1–10; discussion 1–4

  10. Liu PH, Wang JD, Keating NL (2013) Expected years of life lost for six potentially preventable cancers in the United States. Prev Med 56:309–313

    Article  PubMed  Google Scholar 

  11. AIHW (2015) Life expectancy. Australian Institute of Health and Welfare. (http://www.aihw.gov.au/deaths/life-expectancy/) Accessed 7th Apr 2015

  12. AIHW (2013) Cancer in Australia: actual incidence data from 1991 to 2009 and mortality data from 1991 to 2010 with projections to 2012. Asia Pac J Clin Oncol 9:199–213

    Article  Google Scholar 

  13. AIHW, AACR (2012) Cancer in Australia: an overview, 2012. Cancer series 74. Cat. No. CAN 70. Australian Institute of Health and Welfare (AIHW) and Australasian Association of Cancer Registries (AACR), Canberra

  14. Baade PD, Youlden DR, Valery PC et al (2010) Trends in incidence of childhood cancer in Australia, 1983–2006. Br J Cancer 102:620–626

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Baade PD, Youlden DR, Chambers SK (2011) When do I know I am cured? Using conditional estimates to provide better information about cancer survival prospects. Med J Aust 194:73–77

    PubMed  Google Scholar 

  16. Lambert PC, Royston P (2009) Further development of flexible parametric models for survival analysis. Stata J 9:265–290

    Google Scholar 

  17. Royston P, Lambert PC (2011) Flexible parametric survival analysis using stata: beyond the cox model. Stata Press, College Station

    Google Scholar 

  18. Van Ewijk RJ, Schwentner L, Wockel A et al (2013) Trends in patient characteristics, treatment and survival in breast cancer in a non-selected retrospective clinical cohort study of 2600 patients. Arch Gynecol Obstet 287:103–110

    Article  PubMed  Google Scholar 

  19. Roder D, Karapetis CS, Wattchow D et al (2015) Colorectal cancer treatment and survival: the experience of major public hospitals in South Australia over three decades. Asian Pac J Cancer Prev APJCP 16:2431–2440

    Article  PubMed  Google Scholar 

  20. Allemani C, Rachet B, Weir HK et al (2013) Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study. BMJ Open 3:e003055

    Article  PubMed  PubMed Central  Google Scholar 

  21. Rosa F, Alfieri S, Tortorelli AP, Fiorillo C, Costamagna G, Doglietto GB (2014) Trends in clinical features, postoperative outcomes, and long-term survival for gastric cancer: a western experience with 1278 patients over 30 years. World J Surg Oncol 12:217

    Article  PubMed  PubMed Central  Google Scholar 

  22. Wei EK, Wolin KY, Colditz GA (2010) Time course of risk factors in cancer etiology and progression. J Clin Oncol 28:4052–4057

    Article  PubMed  PubMed Central  Google Scholar 

  23. Parkin E, O’Reilly DA, Sherlock DJ, Manoharan P, Renehan AG (2014) Excess adiposity and survival in patients with colorectal cancer: a systematic review. Obes Rev 15:434–451

    Article  PubMed  Google Scholar 

  24. Allott EH, Masko EM, Freedland SJ (2013) Obesity and prostate cancer: weighing the evidence. Eur Urol 63:800–809

    Article  CAS  PubMed  Google Scholar 

  25. Goodwin PJ (2010) Commentary on: “effect of obesity on survival in women with breast cancer: systematic review and meta-analysis” (Melinda Protani, Michael Coory, Jennifer H. Martin). Breast Cancer Res Treat 123:637–640

    Article  PubMed  Google Scholar 

  26. Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123:627–635

    Article  PubMed  Google Scholar 

  27. Allemani C, Weir HK, Carreira H et al (2015) Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385:977–1010

    Article  PubMed  Google Scholar 

  28. Moyer VA, Force USPST (2014) Screening for lung cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 160:330–338

    PubMed  Google Scholar 

  29. Green AC, Baade P, Coory M, Aitken JF, Smithers M (2012) Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia. J Clin Oncol 30:1462–1467

    Article  PubMed  Google Scholar 

  30. Whiteman DC, Baade PD, Olsen CM (2015) More people die from thin melanomas (1 mm) than from thick melanomas (>4 mm) in Queensland, Australia. J Investig Dermatol 135:1190–1193

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the staff of the State and Territory Cancer Registries and the Australian Cancer database, from which these study data were obtained.

Funding

Philippa Youl is funded by a National Health and Medical Research Council Early Career Fellowship (#1054038). The funding body had no input into the study design, the collection, analysis and interpretation of data, the writing of the report or the decision to submit the article for publication.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter D. Baade.

Ethics declarations

Conflict of interest

The authors report no conflict of interest.

Ethical approval

Approval for the use of the anonymized data was provided by all of the individual State and Territory Cancer Registries through the Australian Institute of Health and Welfare (AIHW), with the exception of the Australian Capital Territory (ACT).

Informed consent

Since no individuals were identified nor able to be contacted, informed consent was not required.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 74 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baade, P.D., Youlden, D.R., Andersson, T.M. et al. Temporal changes in loss of life expectancy due to cancer in Australia: a flexible parametric approach. Cancer Causes Control 27, 955–964 (2016). https://doi.org/10.1007/s10552-016-0762-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-016-0762-1

Keywords

Navigation